The Effect of Beetroot Powder on Exercise Performance in Competitive Swimmers
19 juin 2026 mis à jour par: Aysun Köktürk Bayram, Halic University
Swimming requires high energy in a short time and involves overcoming water resistance. Besides regular training, swimmers use supplements to enhance performance, correct nutrient deficiencies, and speed recovery. The Australian Institute of Sport (AIS) classifies supplements by evidence level, with nitrate in Group A. Nitrate aids vasodilation and muscle performance via conversion to nitric oxide (NO).
About 25% of dietary nitrate converts to nitrite by oral bacteria, then to NO in the stomach-a valuable oxygen-independent pathway. NO improves exercise by enhancing oxygen efficiency, muscle contraction, and affecting type II fibers. Timing, dose, nitrate source, and individual traits influence its effect. Beetroot, rich in nitrate, is practical as juice for storage and consumption.
Beetroot gels and juices raise plasma nitrate 1-3 hours post-consumption, effective during 10-17 minute exercises. Some studies found no improvement in short-distance swimming, but others reported dose-dependent benefits. Meta-analyses recommend 5-14.9 mmol nitrate ≥150 minutes before acute exercise, and 5-9.9 mmol for chronic intake. Highly trained athletes may need ≥6-8 mmol NO₃-.
JECFA and the European Commission set acceptable daily intake (ADI) at 0-3.7 mg/kg body weight nitrate ion, safe for all ages.
No long-term, controlled studies exist on beetroot powder's effect in swimmers. To address this, a randomized, placebo-controlled, triple-blind crossover study was designed to evaluate beetroot powder supplementation's impact on competitive swimmers' performance, potentially contributing valuable knowledge.
Aperçu de l'étude
Statut
Complété
Les conditions
Intervention / Traitement
Description détaillée
- Study Design and Participants: This study employed a randomized, double-blind, placebo-controlled crossover design to investigate the effects of beetroot supplementation. Based on a power analysis conducted with a 5% error level and a statistical power of 0.95, a sample size of 36 participants was determined to be sufficient. The study was conducted over a one-year period at the Galatasaray Swimming Club following approval from the institutional ethics committee, and all participants provided written informed consent. Inclusion criteria required voluntary participation with parental consent, an age range of 18-24 years, participation in a structured training program for at least 18 hours per week, no history of chronic disease, no current use of sports or food supplements/medications, and no adherence to a special diet. Conversely, exclusion criteria included irregular training attendance, the presence of chronic diseases, and a failure to cease the use of food supplements one week prior to the study.
- Product Development and Standardization: Three types of beetroot powder were selected from the Turkish market and analyzed by a laboratory accredited under the TURKAK TS EN ISO/IEC 17025:2017 standard, utilizing the HPLC-DAD method in accordance with NMKL No. 165. Based on these analyses, 1.5 g of beetroot powder, corresponding to a 10 mmol nitrate intervention, was used for product development at the Haliç University Nutrition Principles Laboratory. A base mixture of water, gelatin, pectin, starch, and stevia was heated to 85-90°C for homogenization and cooled to 55-60°C. The intervention product contained 1.5 g of beetroot powder, while the placebo product included food coloring to match the visual characteristics of the intervention. Products were prepared 24 hours before each session, stored in opaque, food-safe packaging at 0-4°C, and coded by an independent researcher using a random number generator to ensure triple-blind conditions.
- Experimental Procedure and Controls: Participants were instructed to maintain their habitual dietary intake throughout the study and were provided with a list of nitrate-rich foods to avoid. To prevent interference with oral nitrate-to-nitrite reduction, participants were strictly instructed to abstain from mouthwash, chewing gum, sweets, stimulants, and alcohol on all intervention days. The study consisted of five visits. Visit 1 involved providing study information and obtaining informed consent, while Visit 2 included baseline anthropometric assessments and randomization. Visit 3 involved data collection, including food record retrieval, a standardized warm-up, a 200-m freestyle performance test, and post-test measurements of blood lactate, heart rate, and fatigue. A two-week washout period was implemented between intervention phases to eliminate potential carry-over effects, followed by Visits 4 and 5, where the crossover intervention was conducted by repeating the established testing protocols with the alternative condition.
- Data Collection: Sociodemographic and lifestyle data, including age, sex, education, nutritional habits, and training characteristics, were recorded. Anthropometric measurements included body composition via bioelectrical impedance analysis, height, BMI, and hand grip strength measured by a digital dynamometer. Performance was assessed through a 200-m maximum-effort freestyle swimming test. Physiological assessments included fingertip blood lactate concentration and heart rate (resting, maximum, and average). Finally, subjective fatigue was evaluated using the Perceived Physical and Cognitive Fatigue Scale and the Visual Analog Scale (VAS).
Type d'étude
Interventionnel
Inscription (Réel)
21
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Lieux d'étude
-
-
Kartal
-
Istanbul, Kartal, Turquie (Türkiye)
- Kartal Kosuyolu Yuksek Ihtisas EAH
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
Accepte les volontaires sains
Oui
La description
Inclusion Criteria:
- Voluntary participation with parental consent
- Age range: 18-24 years
- Participation in a training program for at least 18 hours per week
- No history of chronic disease
- Not currently using any sports supplements, food supplements, or medications
- Not following a special diet
Exclusion Criteria:
- Irregular training participation
- Presence of chronic diseases
- Failure to cease the use of food supplements one week prior to the study
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Soins de soutien
- Répartition: Randomisé
- Modèle interventionnel: Affectation croisée
- Masquage: Quadruple
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Beetroot then Placebo
Participants in this arm will first receive 1,5 grams of beetroot powder contain jelly candy daily for 3 consecutive days.
After a 14-day washout period, they will receive placebo jelly candy daily for 3 consecutive days.
|
1.5 g of beetroot powder (equivalent to 10 mmol nitrate) administered as a jelly candy.
Color-matched, nitrate-free jelly candy.
|
|
Comparateur placebo: Placebo then Beetroot
Participants in this arm will first receive placebo jelly candy daily for 3 consecutive days.
After a 14-day washout period, they will receive 1,5 grams of beetroot powder contain jelly candy daily for 3 consecutive days.
|
1.5 g of beetroot powder (equivalent to 10 mmol nitrate) administered as a jelly candy.
Color-matched, nitrate-free jelly candy.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in 200-meter swim performance time
Délai: On the 3rd day of each 3-day intervention period (after beetroot or placebo supplementation).
|
The duration (in seconds) required for the participant to complete a 200-meter freestyle swim, measured using a Seiko stopwatch.
|
On the 3rd day of each 3-day intervention period (after beetroot or placebo supplementation).
|
|
Blood lactate concentration
Délai: Immediately post-exercise on the 3rd day of each 3-day intervention period (after beetroot or placebo supplementation).
|
Blood lactate levels (mmol/L) measured from capillary blood samples collected 3 minutes after completion of 200-meter swim test.
|
Immediately post-exercise on the 3rd day of each 3-day intervention period (after beetroot or placebo supplementation).
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Visual Analog Scale (VAS) for Perceived Fatigue
Délai: On the 3rd day of each 3-day intervention period (after beetroot or placebo supplementation).
|
Participant's self-reported fatigue level assessed using a 10-cm visual analog scale, ranging from 0 (no fatigue) to 10 (extreme fatigue), completed immediately after the swim test.
|
On the 3rd day of each 3-day intervention period (after beetroot or placebo supplementation).
|
|
Heart Rate Change
Délai: On the 3rd day of each 3-day intervention period (after beetroot or placebo supplementation).
|
Maximum heart rate during the 200m swim, heart rate at 1 minute post-performance, and mean heart rate during the test, recorded using a Polar sports watch with an integrated wrist-based optical heart rate monitor.
|
On the 3rd day of each 3-day intervention period (after beetroot or placebo supplementation).
|
|
Change in Perceived Physical and Cognitive Fatigue Scale (AFBYÖ) Scores
Délai: On the 3rd day of each 3-day intervention period (after beetroot or placebo supplementation).
|
The 19-item Perceived Physical and Cognitive Fatigue Scale (PPCFS) is a 5-point Likert-type instrument used to assess athletes' perceived fatigue levels after each training session.
The scale consists of two subscales: the Perceived Physical Fatigue (PPF) subscale, which includes the first 8 items with a total score range of 8 to 40, and the Perceived Cognitive Fatigue (PCF) subscale, which includes the remaining 11 items with a total score range of 11 to 55.
The total score of the scale ranges from 19 to 95, where higher scores in either the subscales or the total score indicate increased levels of physical and cognitive fatigue, respectively.
|
On the 3rd day of each 3-day intervention period (after beetroot or placebo supplementation).
|
|
Daily Energy and Nutrient Intake
Délai: Collected during the 24-hour period prior to the 3rd day of each 3-day intervention period (both beetroot or placebo supplementation).
|
Dietary intake was monitored through 24-hour dietary records kept by participants for 24 hours prior to each measurement day.
Ingredient quantities for composite dishes were calculated using the "Standard Food Recipes" manual.
Subsequently, total daily energy and nutrient intakes were analyzed and quantified using the Nutrition Information System (BeBİS) software.
|
Collected during the 24-hour period prior to the 3rd day of each 3-day intervention period (both beetroot or placebo supplementation).
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Publications et liens utiles
La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Réel)
22 décembre 2025
Achèvement primaire (Réel)
22 mai 2026
Achèvement de l'étude (Réel)
1 juin 2026
Dates d'inscription aux études
Première soumission
16 juin 2026
Première soumission répondant aux critères de contrôle qualité
19 juin 2026
Première publication (Réel)
23 juin 2026
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
23 juin 2026
Dernière mise à jour soumise répondant aux critères de contrôle qualité
19 juin 2026
Dernière vérification
1 mai 2025
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- 2025-08/318
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
NON
Description du régime IPD
Individual participant data (IPD) will not be shared due to concerns regarding participant confidentiality and the small sample size, which may increase the risk of re-identification.
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Non
Étudie un produit d'appareil réglementé par la FDA américaine
Non
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .